Harnessing Computational Design, Automated Workflows & Advanced Sequencing for Faster Screening, Smarter Engineering, Broader Pipeline Diversification & Scalable, Low‑Cost Manufacturing
Advances in AI, machine learning, and predictive enzyme engineering are transforming biocatalysis - unlocking faster, more scalable manufacturing across next-generation modalities.
But with an explosion of new tools, technologies, and providers, one question remains:
Which approaches actually deliver real-world impact, and how do you scale them successfully?
The 6th Applied Biocatalysis & Enzyme Engineering Summit brought together leaders across pharma, biotech, and academia to cut through the noise, benchmark strategies, and validate what’s working today.
Across two days of case-study-driven content and peer-led discussion, attendees:
- Identified which AI and data-driven approaches are delivering measurable ROI
- Explored how to overcome scale-up challenges and move from lab success to industrial application
- Benchmarked their strategies against leading pharma and biotech organisations
- Built partnerships with trusted experts and solution providers
The summit provided a platform for industry leaders to separate AI hype from reality, validate their approaches, and accelerate biocatalysis success.
Speakers Included:
Attending Companies Included